epigallocatechin gallate has been researched along with Lymphoma, Primary Effusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiou, YH; Chou, MC; Huang, MH; Jin, YR; Lin, KH; Shyu, HW; Wang, YF; Yeh, LC | 1 |
| Chen, CY; Chiou, YH; Chou, MC; Huang, MH; Lin, KH; Shyu, HW; Tsai, CY; Wang, YF | 1 |
2 other study(ies) available for epigallocatechin gallate and Lymphoma, Primary Effusion
| Article | Year |
|---|---|
Epigallocatechin-3-gallate downregulates PDHA1 interfering the metabolic pathways in human herpesvirus 8 harboring primary effusion lymphoma cells.
Topics: Catechin; Cell Death; Cell Line, Tumor; Cell Survival; Down-Regulation; Glutarates; Herpesvirus 8, Human; Humans; Lymphoma, Primary Effusion; Metabolic Networks and Pathways; Pyruvate Dehydrogenase (Lipoamide) | 2020 |
Epigallocatechin-3-Gallate Suppresses Human Herpesvirus 8 Replication and Induces ROS Leading to Apoptosis and Autophagy in Primary Effusion Lymphoma Cells.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Autophagy; Catechin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; HEK293 Cells; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphoma, Primary Effusion; Reactive Oxygen Species; Virus Replication | 2017 |